The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
From Emergence to Eradication: The Epidemiology of Poliomyelitis Deconstructed
Open accessAbstract
Poliomyelitis has appeared in epidemic form, become endemic on a global scale, and been reduced to near-elimination, all within the span of documented medical history. Epidemics of the disease appeared in the late 19th century in many European countries and North America, following which polio became a global disease with annual epidemics. During the period of its epidemicity, 1900-1950, the age distribution of poliomyelitis cases increased gradually. Beginning in 1955, the creation of poliovirus vaccines led to a stepwise reduction in poliomyelitis, culminating in the unpredicted elimination of wild polioviruses in the United States by 1972. Global expansion of polio immunization resulted in a reduction of paralytic disease from an estimated annual prevaccine level of at least 600,000 cases to fewer than 1,000 cases in 2000. Indigenous wild type 2 poliovirus was eradicated in 1999, but unbroken localized circulation of poliovirus types 1 and 3 continues in 4 countries in Asia and Africa. Current challenges to the final eradication of paralytic poliomyelitis include the continued transmission of wild polioviruses in endemic reservoirs, reinfection of polio-free areas, outbreaks due to circulating vaccine-derived polioviruses, and persistent excretion of vaccine-derived poliovirus by a few vaccinees with B-cell immunodeficiencies. Beyond the current efforts to eradicate the last remaining wild polioviruses, global eradication efforts must safely navigate through an unprecedented series of endgame challenges to assure the permanent cessation of all human poliovirus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bulletin of the World Health Organization
van der Sande, M. A. B., Walraven, G. E. L., Milligan, P. J., BANYA, W. A. S., CEESAY, S. M., Nyan, O. A., & McAdam, K. P. W. J. (2001) · Bulletin of the World Health Organization · Cited by 7,097
Bulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
Bulletin of the World Health Organization
Frick, K. D., Lynch, M. C., West, S. K., Muñoz, B., & Mkocha, H. A. (2003) · Bulletin of the World Health Organization · Cited by 2,660
Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature
Lowen, A. C., Mubareka, S., Steel, J., & Palese, P. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030151 · Cited by 1,669
NEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Self-citationDevelopments in Biological Standardization
Miller, E. (1993) · Journal of Epidemiology and Community Health · doi:10.1136/jech.47.1.78-b · Cited by 678
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
Self-citationMurayama, K. M. (2007) · Cited by 477
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review.
Patriarca, P. A., Wright, P. F., & John, T. J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.926 · Cited by 453
Molecular Biology Of Picornaviruses
Semler, B. L., & Wimmer, E. (2002) · Cited by 452
The principles of disease elimination and eradication
Dowdle, W. R. (1998) · PubMed · doi:10.5281/zenodo.18192410 · Cited by 424
Turner, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92377-5 · Cited by 388
Virus Survival as a Seasonal Factor in Influenza and Poliomyelitis
HEMMES, J. H., WINKLER, K. C., & KOOL, S. M. (1960) · Nature · doi:10.1038/188430a0 · Cited by 342
Strebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
Self-citationGeographic distribution of wild poliovirus type 1 genotypes
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., & Kew, O. M. (1987) · Virology · doi:10.1016/0042-6822(87)90001-8 · Cited by 328
Self-citationOne hundred years of poliovirus pathogenesis
Racaniello, V. R. (2006) · Virology · doi:10.1016/j.virol.2005.09.015 · Cited by 322 · cited 1×
“Because the poliovirus receptor is only expressed on cells of humans and a few subhuman primate species, there are no known extrahuman reservoirs (7, 8).”
BackgroundNew Strategies for the Elimination of Polio from India
Grassly, N. C., Fraser, C., Wenger, J., Deshpande, J. M., Sutter, R. W., Heymann, D. L., & Aylward, R. B. (2006) · Science · doi:10.1126/science.1130388 · Cited by 271
Circulating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · PubMed · doi:10.1590/s0042-96862004000100006 · Cited by 258
Self-citationEmerging Concept of Poliomyelitis Infection
Bodian, D. (1955) · Science · doi:10.1126/science.122.3159.105 · Cited by 251
Fine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984
Nkowane, B. M. (1987) · JAMA · doi:10.1001/jama.257.10.1335 · Cited by 240
Pathogenesis of Poliomyelitis Reappraisal in the Light of New Data
Sabin, A. B. (1956) · Science · doi:10.1126/science.123.3209.1151 · Cited by 236
The molecular biology of poliovaccines
Minor, P. D. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-12-3065 · Cited by 217
NATHANSON, N., & MARTIN, J. R. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112848 · Cited by 214 · cited 4×
“Only 1 in 150 primary poliovirus infections causes paralytic poliomyelitis; since most infections are subclinical, paralytic cases represent only the ‘‘tip of the epidemiologic iceberg’’ (4).”
BackgroundInfluentialSelf-citationProlonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
Kew, O. M., Sutter, R. W., Nottay, B. K., McDonough, M. J., Prevots, D. R., Quick, L., & Pallansch, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2893-2899.1998 · Cited by 213
Self-citationPaul, J. R. (1971) · Cited by 208
Vaccine Policy Changes and Epidemiology of Poliomyelitis in the United States
Alexander, L. N. (2004) · JAMA · doi:10.1001/jama.292.14.1696 · Cited by 203
Eradication versus control for poliomyelitis: an economic analysis
Thompson, K. M., & Tebbens, R. J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60532-7 · Cited by 200
Present Position of Immunization Against Poliomyelitis with Live Virus Vaccines
Sabin, A. B. (1959) · BMJ · doi:10.1136/bmj.1.5123.663 · Cited by 198
Formaldehyde Treatment and Safety Testing of Experimental Poliomyelitis Vaccines
Salk, J. E., Krech, U., Youngner, J. S., Bennett, B. L., Lewis, L. J., & Bazeley, P. L. (1954) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.44.5.563 · Cited by 183
Sabin, A. B. (1960) · JAMA · doi:10.1001/jama.1960.03020320001001 · Cited by 182 · cited 2×
“When OPV is administered to children who are concurrently infected with other enteroviruses, the proportion of vaccinees who become OPV-infected and develop an immune response against poliovirus is reduced (45).”
BackgroundCalibration of multiple poliovirus molecular clocks covering an extended evolutionary range
Jorba, J., Campagnoli, R., De, L., & Kew, O. (2008) · Journal of Virology · doi:10.1128/jvi.02354-07 · Cited by 177
Self-citationFractional Doses of Inactivated Poliovirus Vaccine in Oman
Mohammed, A. J., AlAwaidy, S., Bawikar, S., Kurup, P. J., Elamir, E., Shaban, M. M. A., Sharif, S. M., van der Avoort, H. G. A. M., Pallansch, M. A., Malankar, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909383 · Cited by 172
Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Self-citationMacLennan, C., Dunn, G., Huissoon, A. P., Kumararatne, D. S., Martin, J., O'Leary, P., Thompson, R. A., Osman, H., Wood, P., Minor, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16150-3 · Cited by 162
Molecular epidemiology of polioviruses
Kew, O. M., Mulders, M. N., Lipskaya, G. Y., da Silva, E. E., & Patlansch, M. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80017-4 · Cited by 157 · cited 2×
“It has been possible to certify the disappearance of indigenous wild polioviruses in entire countries and large geographic regions (25–27) because the nucleotide sequences of wild polioviruses indigenous to different parts of the world are readily distinguishable (28).”
BackgroundSelf-citationProtective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study
Grassly, N. C., Wenger, J. D., Durrani, S., Bahl, S. K., Deshpande, J. M., Sutter, R. W., Heymann, D. L., & Aylward, R. B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60531-5 · Cited by 156
Resik, S., Tejeda, A., Lago, P. M., Díaz, M., Carmenates, A., Sarmiento, L., Alemañy, N., Galindo, B., Burton, A. H., Friede, M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/651611 · Cited by 147
Poliovirus and poliomyelitis: A tale of guts, brains, and an accidental event
Mueller, S., Wimmer, E., & Cello, J. (2005) · Virus Research · doi:10.1016/j.virusres.2005.04.008 · Cited by 133
Bodian, D. (1952) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.42.11.1388 · Cited by 126
Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., & Kew, O. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11153-11161.2000 · Cited by 119
Self-citationPoliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba
Lago, P. M., Gary, H. E., Sarmiento, L., Cáceres, V. M., Olivera, J. B., Puentes, R. P., Corredor, M. B., Jímenez, P., Pallansch, M. A., & Cruz, R. G. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg185 · Cited by 117
Paralytic Disease Associated With Oral Polio Vaccines
Henderson, D. A., Witte, J. J., Morris, L., & Langmuir, A. D. (1964) · JAMA · doi:10.1001/jama.1964.03070140047006 · Cited by 108
Vaccine-Associated Paralytic Poliomyelitis
Beausoleil, J. L., Nordgren, R. E., & Modlin, J. F. (1994) · Journal of Child Neurology · doi:10.1177/088307389400900324 · Cited by 108
Apparent global interruption of wild poliovirus type 2 transmission.
(2001) · PubMed · Cited by 107
Henry, J. L., Jaikaran, E. S., Davies, J. R., Tomlinson, A. J. H., Mason, P. J., Barnes, J. M., & Beale, A. J. (1966) · Journal of Hygiene · doi:10.1017/s0022172400040389 · Cited by 101
Virus survival as a seasonal factor in influenza and poliomyelitis
Hemmes, J. H., Winkler, K. C., & Kool, S. M. (1962) · Antonie van Leeuwenhoek · doi:10.1007/bf02538737 · Cited by 96
Chapter 1 The Pathogenesis of Poliomyelitis: What We Don't Know
Nathanson, N. (2008) · Advances in Virus Research · doi:10.1016/s0065-3527(08)00001-8 · Cited by 95
Self-citationPoliovirus Vaccine–Inactivated
Vidor, E. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00047-x · Cited by 89
(2006) · PubMed · Cited by 87
Vaccination against polio should not be stopped
Chumakov, K., Ehrenfeld, E., Wimmer, E., & Agol, V. I. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1769 · Cited by 85
Eradication of Wild Poliovirus from the Americas: Acute Flaccid Paralysis Surveillance, 1988-1995
de Quadrós, C. A., Hersh, B. S., Olive, J.-M., Andrus, J. K., da Silveira, C. M., & Carrasco, P. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s37 · Cited by 85
Monovalent Type 1 Oral Poliovirus Vaccine in Newborns
El-Sayed, N., El‐Gamal, Y., Abbassy, A.-A., Seoud, I., Salama, M., Kandeel, A., Hossny, E. M., Shawky, A., Hussein, H. A., Pallansch, M. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800390 · Cited by 83
The Risks, Costs, and Benefits of Possible Future Global Policies for Managing Polioviruses
Thompson, K. M., Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Sutter, R. W., Aylward, R. B., Watkins, M., Gary, H. E., Alexander, J. P., Jafari, H. S., et al. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.122192 · Cited by 81
Self-citationThe Control of Poliomyelitis in Brazil
Risi, J. B. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s400 · Cited by 76
VACCINE-ASSOCIATED POLIOMYELITIS IN THE UNITED STATES, 1961–19721
Schonberger, L. B., McGowan, J. E., & Gregg, M. B. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112290 · Cited by 75
Estimating the Extent of Vaccine-Derived Poliovirus Infection
Wringe, A., Fine, P., Sutter, R. W., & Kew, O. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003433 · Cited by 75
Self-citationResolution of the Pathways of Poliovirus Type 1 Transmission during an Outbreak
Shulman, L. M., Handsher, R., Yang, C.-F., Yang, S.-J., Manor, J., Vonsover, A., Grossman, Z., Pallansch, M., Mendelson, E., & Kew, O. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.945-952.2000 · Cited by 74
Self-citationHuang, Q. S., Greening, G. E., Baker, M. G., Grimwood, K., Hewitt, J., Hulston, D. A., van Duin, L., Fitzsimons, A., Garrett, N., Graham, D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66386-6 · Cited by 73
THE INCUBATION PERIOD IN HUMAN POLIOMYELITIS AND ITS IMPLICATIONS
Horstmann, D. M., & PAUL, J. R. (1947) · JAMA · doi:10.1001/jama.1947.02890010013004 · Cited by 72
Agol, V. I. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.007 · Cited by 71
Effectiveness of Immunization against Paralytic Poliomyelitis in Nigeria
Jenkins, H. E., Aylward, R. B., Gasasira, A. N., Donnelly, C. A., Abanida, E. A., Koleosho-Adelekan, T., & Grassly, N. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803259 · Cited by 67
Poliomyelitis Eradication--a Dangerous Endgame
Nathanson, N., & Fine, P. (2002) · Science · doi:10.1126/science.1071207 · Cited by 66
Self-citationDisease eradication as a public health strategy: a case study of poliomyelitis eradication.
Aylward, R. B., Hull, H. F., Cochi, S. L., Sutter, R. W., Olivé, J. M., & Melgaard, B. (2000) · Europe PMC (PubMed Central) · Cited by 66
Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009.
Div, G. I. (2009) · MMWR Morbidity and Mortality Weekly Report · Cited by 66
Melnick, J. L., & Ledinko, N. (1953) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119602 · Cited by 65
Polio vaccines and polio immunization in the pre-eradication era: WHO position paper—Recommendations
Publication, W. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.023 · Cited by 64
Dowdle, W., Van Der Avoort, H., De Gourville, E., Delpeyroux, F., Desphande, J., Hovi, T., Martin, J., Pallansch, M., Kew, O., & Wolff, C. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00844.x · Cited by 61
Self-citationPolio vaccines and polio immunization in the pre-eradication era: WHO position paper.
(2010) · PubMed · Cited by 61
Eradication of Poliomyelitis in the United States
Nathanson, N. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.5.940 · Cited by 59
Self-citationChumakov, K., & Ehrenfeld, E. (2008) · Clinical Infectious Diseases · doi:10.1086/593310 · Cited by 58
DIFFERENTIATION OF TYPES OF POLIOMYELITIS VIRUSES
Bodian, D. (1949) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119271 · Cited by 56
Pathogens of Siphonaptera (fleas).
Castillo, J. M. (1980) · Europe PMC (PubMed Central) · Cited by 50
Cockburn, W. C., & Drozdov, S. G. (1970) · PubMed · Cited by 49
Lago, P. M., Cáceres, V. M., Galindo, M. A., Gary, H. E., Valcárcel, M., Barrios, J., Sarmiento, L., Avalos, I., Bravo, J. A., Palomera, R., et al. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.5.1029 · Cited by 49
Cuba: Mass Polio Vaccination Program, 1962–1982
Cruz, R. R. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s408 · Cited by 46
Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009.
(2009) · PubMed · Cited by 46
The Incubation Period of Poliomyelitis
Sartwell, P. E. (1952) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.42.11.1403 · Cited by 44
Yoneyama, T., Hagiwara, A., Hara, M., & Shimojo, H. (1982) · Infection and Immunity · doi:10.1128/iai.37.1.46-53.1982 · Cited by 44
Update on vaccine-derived polioviruses--worldwide, January 2008-June 2009.
(2009) · PubMed · Cited by 43
Immunisation against poliomyelitis: moving forward
Ehrenfeld, E., Glass, R. I., Agol, V. I., Chumakov, K., Dowdle, W. R., John, T. J., Katz, S. L., Miller, M. D., Breman, J. G., Modlin, J. F., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60597-8 · Cited by 41
The role of routine polio immunization in the post-certification era.
Sutter, R. W., Cáceres, V. M., & Lago, P. M. (2004) · Europe PMC (PubMed Central) · Cited by 40
Polio control after certification: major issues outstanding.
Fine, P., Oblapenko, G., & Sutter, R. W. (2004) · Europe PMC (PubMed Central) · Cited by 38
The Vaccine Origin of the 1968 Epidemic of Type 3 Poliomyelitis in Poland
Martín, J. E.-S., Ferguson, G. L., Wood, D. J., & Minor, P. D. (2000) · Virology · doi:10.1006/viro.2000.0614 · Cited by 37
A Survey of Poliomyelitis Virus Antibodies in French Morocco
Paul, J. R., & Horstmann, D. M. (1955) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1955.4.512 · Cited by 36
(2007) · PubMed · Cited by 34
Ab, S., Ramos-Alvarez, M., Alvarezamezquita, J., Pelon, W., Rh, M., Spigland, I., Koch, M. A., Barnes, J. M., & Rhim, J. S. (1999) · PubMed Central · Cited by 31
Is there an ethical obligation to complete polio eradication?
Emerson, C., & SINGER, P. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60565-x · Cited by 31
A vision of a world without polio: The OPV cessation strategy
Heymann, D. L., Sutter, R. W., & Aylward, R. B. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.03.005 · Cited by 29
Epidemiologic Aspects of Poliomyelitis Eradication
Nathanson, N. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s308 · Cited by 26
Self-citationGlobal Eradication of Poliovirus:History and Rationale
Dowdle, W. R., & Cochi, S. L. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch38 · Cited by 24
Status of the Eradication of Indigenous Wild Poliomyelitis in the People's Republic of China
Wang, K.-A., Zhang, L.-B., Otten, M. W., Zhang, X., Chiba, Y., Zhang, R.-Z., Xu, T., Liu, X., Liu, M., Li, Q.-L., et al. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s105 · Cited by 24
Deeny, J., & MacCormack, J. D. (1946) · The Lancet · doi:10.1016/s0140-6736(46)90656-3 · Cited by 24
Perspective: Determinants of the Severity of Poliovirus Outbreaks in the Post Eradication Era
Fine, P., & Ritchie, S. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00855.x · Cited by 22
Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.
(2006) · PubMed · Cited by 21
Interrupting poliovirus transmission – New solutions to an old problem
Aylward, R. B., & Maher, C. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.012 · Cited by 18
Certification of poliomyelitis eradication. WHO Western Pacific Region, October 2000.
(2000) · PubMed · Cited by 18
Surveillance for Polio Eradication in the People's Republic of China
Zhang, J., Zhang, L.-B., Otten, M. W., Jiang, T., Zhang, X., Zhang, R.-Z., & Wang, K.-A. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s122 · Cited by 17
Roberts, L. (2009) · Science · doi:10.1126/science.323.5915.702 · Cited by 16
Poliomyelitis. Papers and Discussions Presented at the Second International Poliomyelitis Conference
Chason, J. L. (1953) · American Journal of Clinical Pathology · doi:10.1093/ajcp/23.7.696a · Cited by 15
BODIAN, D. (1951) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119476 · Cited by 13
The epidemiology of poliomyelitis in Burma.
Lb, S., Thaung, U., Dk, K., Swe, T., Mo, K., & Bregman, D. J. (1981) · PubMed · Cited by 3
Progress towards eradicating poliomyelitis in Nigeria, January 2009- June 2010.
(2010) · PubMed · Cited by 3
Cited by
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
Xing, W., Liao, Q., Viboud, C., Zhang, J., Sun, J., Wu, J. T., Chang, Z., Liu, F., Fang, V. J., Zheng, Y., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70342-6 · Cited by 927
A new twenty-first century science for effective epidemic response
Bedford, J., Farrar, J., Ihekweazu, C., Kang, G., Koopmans, M., & Nkengasong, J. (2019) · Nature · doi:10.1038/s41586-019-1717-y · Cited by 313
Burns, C. C., Diop, O. M., Sutter, R. W., & Kew, O. M. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu295 · Cited by 309
Self-citationBurns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153
Self-citationCombelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
Metadata
- Authors
- Nathanson, N., & Kew, O. M.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10-26
- Volume
- 172
- Issue
- 11
- Pages
- 1213-1229
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2151618428
- Cited by
- 404
- References
- 104
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.